Answers are grounded in this paper and cite their sources.
Results are compatible with worldwide studies and lymphopenia is valid as a marker of disease severity and mortality.
No takes yet. Share an insight, caveat, or question.
Toori et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: